Innocoll Holdings PLC (NDAQ:INNL) was downgraded by research analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a research note issued to investors on Friday. They presently have a $2.00 price objective on the stock.
Shares of Innocoll Holdings PLC (NDAQ:INNL) opened at 1.12 on Friday. The stock’s 50 day moving average price is $0.78 and its 200-day moving average price is $2.97. Innocoll Holdings PLC has a 52 week low of $0.53 and a 52 week high of $12.94. The firm’s market capitalization is $33.26 million.
var userip;Your IP Address: document.write(userip);
About Innocoll Holdings PLC
Innocoll Holdings Public Limited Company is a commercial-stage specialty pharmaceutical and medical device company with late-stage development programs. The Company operates through the segment of manufacture and sale of collagen-based pharmaceutical products. It utilizes collagen-based technology platform to develop its biodegradable and bioresorbable products and product candidates, which can be broken down by the body without the need for surgical removal or applied topically.
Receive News & Ratings for Innocoll Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innocoll Holdings PLC and related companies with MarketBeat.com's FREE daily email newsletter.